nach oben

Indian Journal of Otolaryngology and Head & Neck Surgery

Erschienen in:

Open Access 03.03.2023 | Original Article

Serum Parathyroid Hormone and Vitamin D Levels as Predictors of Hypocalcemia after Total/ Near Total Thyroidectomy

verfasst von: Priya Dugani, Poorvi V Sharma, Sunil M Krishna, Krishna Kalyan Reddy

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Ausgabe 3/2023

Abstract

Background: Post-operative Hypocalcaemia is the most-common complication of total and near-total thyroidectomy which is a selective treatment for benign and malignant thyroid diseases. Incidence ranges from 0.5-50%. Objectives: The role of vitamin-D and Parathyroid hormone(PTH) in incidence of Hypocalcemia after thyroidectomy has been taken into consideration. Methods: This is a prospective interventional study is conducted in Kasturba Medical College and hospital, Manipal after taking written informed consent from the participants. It aimed at surveying the serum level of preoperative Vitamin D, PTH and calcium before total-thyroidectomy surgery and its relationship with the incidence of postoperative hypocalcemia after the surgery. The study was done on 70 patients who were-planned for total/near total thyroidectomy. Preoperative Vitamin D, PTH, calcium and Postoperative 4 hours-PTH, Calcium were measured on POD-1, POD-2-4, the results obtained were then analysed. Results: Considering the cut-off of calcium as 8.6mg/dl, 42 patients developed hypocalcemia on POD-1, 28 patients on POD-2. Preoperative calcium and postoperative PTH levels in people having hypocalcaemia where significantly less compared to the patients having normal calcium. 4-hours post-operative PTH measurements showed 51% sensitivity, 100% specificity and strong co-relation between postoperative hypocalcemia and drop in PTH levels- (p=<0.001). Out of 42 patients who developed hypocalcemia 28- (65%) patients had vitamin-D deficiency(p=0.5) on POD-1 and out of 51 patients with hypocalcemia on POD 2-4, 33(78%) had-vitamin-D-deficiency(p=0.3852). Which was not statically significant. Conclusion:4 hours post-operative PTH level is a predictor of early postoperative hypocalcemia, by detecting this we can effectively manage postoperative hypocalcemia

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Due to the increased number of thyroid malignancies, the patients undergoing total thyroidectomies has also increased. Post operative Hypocalcemia have also increased as it is the most common complication of total and near total thyroidectomy. Incidence ranges from 0.5 to 50% in post-operative patients [1]. Which occurs approximately 24–48 h post total or near total thyroidectomy surgeries.

Patients may have post op- paraesthesia, tingling, carpopedal spasm, cramps and numbness of extremities and perioral area. Chvostek sign, Trousseau sign, laryngospasm due to sustained muscle contraction, confusion, irritability and if prolonged may present with seizures. Prolonged QT interval may lead to torsades de pointes ventricular fibrillation [2].

The parathyroid glands are very fragile and supplied by Inferior thyroid artery. The short half-life of parathyroid hormone is 3–5 min which easily predisposes patients to hypocalcemia. Hypocalcemia may occur due to surgical trauma, devascularization, unintentional removal of parathyroid glands, reoperation. Even after meticulously performed procedures, some temporary parathyroid dysfunction may occur. Surgical excision/manipulation/ disruption of blood supply has been seen as a risk factor. The recommended surgical strategy is meticulous dissection and preservation of the parathyroid glands and their blood supply. Risk of complication is higher when fewer than three glands are identified during surgery. Depending upon the extent of parathyroid damage, postoperative hypocalcemia may be transient, which may resolve within a few months, or permanent, requiring lifelong oral or intravenous calcium supplementation [3, 4].

Vitamin D deficiency increases gut calcium absorption and also stimulates synthesis of PTH to maintain normal serum calcium levels [5]. Studies have shown that association between postoperative hypocalcemia and vitamin D deficiency leads to a longer hospital stay.

Definite framework in terms of post operative early identification of patients at risk of hypocalcaemia would allow for prophylactic treatment hence avoiding development of symptomatic hypocalcaemia and need for prolonged hospital stay.

Therefore, in our prospective interventional study, we have investigated the association between postoperative 4 h PTH and vitamin D with postoperative symptomatic and biochemical hypocalcemia in patients undergoing total and near total thyroidectomy.

Methods

This was a single centred prospective interventional study conducted in the Department of General Surgery, surgical oncology and ENT at Kasturba Medical College and Hospital, Manipal between March 2021 to November 2022 after obtaining institutional ethics committee approval and written consent form all the 70 research participants. This study was sponsored by Roche Diagnostic India Pvt Ltd.

Patients above the age of 18 yrs who were planned for total and near total thyroidectomy surgeries were included in the study.

We excluded the patients who were on Calcium or Vitamin D supplementation, pre-excisting parathyroid disorders, hypocalcemia, paraneoplastic syndromes, chronic kidney disease or patients who had undergone previous neck dissections, thyroid surgeries, radiation to the neck, or auto-transplant of parathyroid gland.

Relevant preoperative details such as clinical, radiological, biochemical and pathological investigations. Pre-operative PTH, vitamin D and serum calcium were measured. After total or near total thyroidectomy at an interval of 4 hour, PTH was repeated, and POD 1, and 48 to 72 hour later serum calcium was repeated which was the standard of care. Signs and symptoms of hypocalcemia were observed. The patients were followed up till discharge and upto 3 months when the patient came for regular follow up to the OPD with serum calcium.

Data was coded and recorded in MS Excel spreadsheet program. SPSS v23 (IBM Corp.) and was used for data analysis.

Results

The study population included 70 patients with the average age of 46.03 ± 13.41. Ten patients (14.3%) were males and 60 (85.7%) were females. 67 (95.7%) patients had neck swelling. 2 patients had hoarseness of voice, one patient had dysphagia with stridor and another patient had shortness of breath preoperatively. 69(patients where euthyroid (98.6%) and 1 patient had hypothyroidism. 27 (38.6%) patients had TIRADS 2 category on preoperative USG and 25 (35.7%) patients had TIRADS 4 category. 32 (47.8%) patients had FNAC report of colloid goiter. 6 (8.6%) patients underwent near total thyroidectomy and 64 (91.4%) underwent total thyroidectomy. Parathyroid gland and inferior thyroid artery was preserved in all cases. These parameters were not found to be statically significant in predicting biochemical or symptomatic hypocalcemia (Tables 1 and 2).

Table 1

Biochemical hypocalcaemia and its association with various parameters

Parameters	Yes (n = 51)	p value
Age (Years)	47.27 ± 13.69	0.262¹
Age		0.899²
21–30 Years	4 (7.8%)
31–40 Years	15 (29.4%)
41–50 Years	13 (25.5%)
51–60 Years	7 (13.7%)
61–70 Years	9 (17.6%)
71–80 Years	3 (5.9%)
Gender		0.713²
Male	7 (13.7%)
Female	44 (86.3%)
Neck Swelling (Yes)	48 (94.1%)	0.562²
Pressure Symptoms		0.711²
No	48 (94.1%)
Horseness Of Voice	1 (2.0%)
Dysphagia With Stridor	1 (2.0%)
Shortness Of Breath	1 (2.0%)
TFT		1.000²
Normal	50 (98.0%)
Hypothyroidism	1 (2.0%)
USG Neck		0.887²
Tirads 1	5 (9.8%)
Tirads 2	21 (41.2%)
Tirads 3	1 (2.0%)
Tirads 4	17 (33.3%)
Tirads 5	5 (9.8%)
Thyroiditis	1 (2.0%)
Solitary Thyroid Nodule	1 (2.0%)
FNAC: Colloid Goiter (Yes)	21 (41.2%)	0.092³
FNAC: Adenomatoid Nodule (Yes)	4 (7.8%)	1.000²
FNAC: Papillary Carcinoma (Yes)	8 (15.7%)	0.186²
FNAC: Nodular Goiter (Yes)	2 (3.9%)	1.000²
FNAC: Follicular Neoplasm (Yes)	8 (15.7%)	0.477²
FNAC: Thyroiditis (Yes)	3 (5.9%)	0.568²
FNAC: Others (Yes)	6 (11.8%)	0.670²
Procedure		1.000²
Near Total Thyroidectomy	5 (9.8%)
Total Thyroidectomy	46 (90.2%)
Parathyroid (Preserved)	51 (100.0%)	1.000³
Inferior Thyroid Artery (Preserved)	51 (100.0%)	1.000³
Vitamin D (ng/mL) (Pre-Operative)	19.18 ± 9.09	0.216⁴
Vitamin D (Pre-Operative)		0.385²
<20 ng/mL	33 (64.7%)
20–30 ng/mL	14 (27.5%)
≥30 ng/mL	4 (7.8%)
PTH (pg/mL) (Pre-Operative)	48.05 ± 20.03	0.848⁴
PTH (pg/mL) (Post-Operative 4 h)***	19.00 ± 16.02	0.001⁴
PTH (Pre-Operative)		0.715²
15–65 pg/mL	42 (82.4%)
>65 pg/mL	9 (17.6%)
PTH (Post-Operative 4 h)***		< 0.001³
<15 pg/mL	28 (54.9%)
15–65 pg/mL	23 (45.1%)
Calcium (mg/dL) (Pre-Operative)	9.04 ± 0.44	0.230⁴
Calcium (mg/dL) (POD 1)***	8.16 ± 0.57	< 0.001¹
Calcium (mg/dL) (POD 2–4)***	7.78 ± 0.60	< 0.001⁴
Calcium (mg/dL) (3 Months)	8.99 ± 0.87	0.061⁴
Biochemical Hypocalcemia (Pre-Operative) (Yes)	8 (15.7%)	0.101²
Biochemical Hypocalcemia (POD 1) (Yes)***	42 (60.0%)	< 0.001³
Biochemical Hypocalcemia (POD 2–4) (Yes)***	51 (73.9%)	< 0.001³
Biochemical Hypocalcemia (3 Months) (Yes)	10 (22.7%)	0.098²
Symptomatic Hypocalcemia (Yes)***	25 (49.0%)	0.001³
Post Operative Complications		1.000²
No	49 (96.1%)
Horseness Of Voice	2 (3.9%)
Post Operative Management: No (Yes)	9 (17.6%)	0.102²
Post Operative Management: IV Calcium (Yes)***	18 (35.3%)	0.015²
Post Operative Management: Oral Calcium (Yes)	41 (80.4%)	0.121²
Post Operative Management: Vitamin D (Yes)	14 (27.5%)	0.528²
Discharged with Calcium Supplementation: No (Yes)	9 (18.4%)	0.205²
Discharged with oral Calcium and vitamin DSupplementation	40 (81.6%)	0.205²
Final HPE Impression		1.000³
Benign	34 (66.7%)
Malignant	17 (33.3%)
Change in PTH (pg/mL) (Post-Operative 4 h)***	-29.05 ± 22.81	0.032⁴

Table 2

Symptomatic hypocalcaemia and its association with various parameters

Parameters	Yes (n = 26)	P value
Age (Years)	44.65 ± 13.74	0.518¹
Age		0.682²
21–30 Years	4 (15.4%)
31–40 Years	8 (30.8%)
41–50 Years	6 (23.1%)
51–60 Years	3 (11.5%)
61–70 Years	3 (11.5%)
71–80 Years	2 (7.7%)
Gender		0.734²
Male	3 (11.5%)
Female	23 (88.5%)
Neck Swelling (Yes)	25 (96.2%)	1.000²
Pressure Symptoms		0.441²
No	25 (96.2%)
Horseness Of Voice	0 (0.0%)
Dysphagia With Stridor	0 (0.0%)
Shortness Of Breath	1 (3.8%)
TFT		1.000²
Normal	26 (100.0%)
Hypothyroidism	0 (0.0%)
USG Neck		0.775²
Tirads 1	3 (11.5%)
Tirads 2	13 (50.0%)
Tirads 3	0 (0.0%)
Tirads 4	9 (34.6%)
Tirads 5	1 (3.8%)
Thyroiditis	0 (0.0%)
Solitary Thyroid Nodule	0 (0.0%)
FNAC: Colloid Goiter (Yes)	10 (38.5%)	0.226³
FNAC: Adenomatoid Nodule (Yes)	0 (0.0%)	0.149²
FNAC: Papillary Carcinoma (Yes)	5 (19.2%)	0.143²
FNAC: Nodular Goiter (Yes)	2 (7.7%)	0.552²
FNAC: Follicular Neoplasm (Yes)	5 (19.2%)	0.754²
FNAC: Thyroiditis (Yes)	1 (3.8%)	1.000²
FNAC: Others (Yes)	3 (11.5%)	1.000²
Procedure		0.078²
Near Total Thyroidectomy	0 (0.0%)
Total Thyroidectomy	26 (100.0%)
Parathyroid (Preserved)	26 (100.0%)	1.000³
Inferior Thyroid Artery (Preserved)	26 (100.0%)	1.000³
Vitamin D (ng/mL) (Pre-Operative)	20.18 ± 9.53	0.771⁴
Vitamin D (Pre-Operative)		0.537²
<20 ng/mL	15 (57.7%)
20–30 ng/mL	8 (30.8%)
≥30 ng/mL	3 (11.5%)
PTH (pg/mL) (Pre-Operative)	47.46 ± 22.85	0.789⁴
PTH (pg/mL) (Post-Operative 4 h)***	11.45 ± 11.20	< 0.001⁴
PTH (Pre-Operative)		1.000²
15–65 pg/mL	22 (84.6%)
>65 pg/mL	4 (15.4%)
PTH (Post-Operative 4 h)***		< 0.001³
<15 pg/mL	20 (76.9%)
15–65 pg/mL	6 (23.1%)
Calcium (mg/dL) (Pre-Operative)	9.03 ± 0.40	0.137⁴
Calcium (mg/dL) (POD 1)***	7.93 ± 0.58	< 0.001¹
Calcium (mg/dL) (POD 2–4)***	7.48 ± 0.64	< 0.001¹
Calcium (mg/dL) (3 Months)***	8.79 ± 1.05	0.038⁴
Biochemical Hypocalcemia (Pre-Operative) (Yes)	3 (11.5%)	1.000²
Biochemical Hypocalcemia (POD 1) (Yes)***	22 (84.6%)	0.001³
Biochemical Hypocalcemia (POD 2–4) (Yes)***	25 (96.2%)	0.001³
Biochemical Hypocalcemia (3 Months) (Yes)***	7 (30.4%)	0.037²
Biochemical Hypocalcemia (Yes)***	25 (100.0%)	0.001³
Post Operative Complications		0.289²
No	26 (100.0%)
Horseness Of Voice	0 (0.0%)
Post Operative Management: No (Yes)***	1 (3.8%)	0.002³
Post Operative Management: IV Calcium (Yes)***	17 (65.4%)	< 0.001³
Post Operative Management: Oral Calcium (Yes)***	25 (96.2%)	0.001³
Post Operative Management: Vitamin D (Yes)***	13 (50.0%)	< 0.001³
Discharged Oral Calcium and vitamin D supplementation(Yes)***	24 (96.0%)	0.004³
Final HPE Impression		0.775³
Benign	18 (69.2%)
Malignant	8 (30.8%)
Change in PTH (pg/mL) (Post-Operative 4 h)***	-36.01 ± 22.89	0.001⁴

Mean preoperative calcium, PTH and vitamin D and PTH 4 h post operative, and calcium on POD 1, 2–4 days after surgery have been presented in the Table 3. Preoperative PTH was found to be within normal range in 59 (84.3%) patients and elevated in 11 (15.7%), and post operative 4 h, 42 (60%) had PTH between 15 and 65 pg/mL (normal range) and 28 (40%) patients had low levels of PTH(< 15 pg/mL).

Table 3

Mean pre and postoperative PTH and calcium distribution

PTH	Mean ± SD, Frequency (%)
Pre-Operative
15–65 pg/mL	59 (84.3%)
>65 pg/mL	11 (15.7%)
Post-Operative 4 h
<15 pg/mL	28 (40.0%)
15–65 pg/mL	42 (60.0%)
Calcium (mg/dL)	Mean ± SD
Pre-Operative	9.07 ± 0.41
POD 1	8.33 ± 0.62
POD 2–4	8.08 ± 0.73
3 Months	9.11 ± 0.80

Preoperative Vitamin D deficiency was noted in 43 (61.4%) study population, 22 (31.4%) had vitamin D in the normal range and 5 (7.1%) patients had elevated levels of vitamin D as shown in Table 4.

Table 4

Frequency of vitamin D( preoperative)

Vitamin D (Pre-Operative)	Frequency
< 20 ng/mL	43 (61.4%)
20–30 ng/mL	22 (31.4%)
≥ 30 ng/mL	5 (7.1%)
Hypocalcemia	Yes
Biochemical Hypocalcemia	51 (73.9%)
Symptomatic Hypocalcemia	26 (37.1%)

On POD 1 serum calcium ranged from 8.33 ± 0.62 ml/dl and 8.08 ± 0.73 ml/dl on POD 2–4.

On POD 1, 42 (60.0%) patients, on POD 2–4, 51 (73.9%) patients developed biochemical hypocalcaemia. 10 (16.9%) patients had persistent hypocalcemia on 3 months follow up as depicted in Table 5.

Table 5

Population who developed post operative biochemical hypocalcemia

Biochemical Hypocalcemia	Yes
POD 1	42 (60.0%)
POD 2–4	51 (73.9%)
3 Months	10 (16.9%)

27 (49%) patients developed symptomatic hypocalcemia, of which 25 (49.0%) had biochemical hypocalcemia and 2 (5.6%) patients did not have biochemical hypocalcemia.

On POD 1, post operative 4 hour PTH was measured, 24 (85.7%) patients had low levels of PTH, 18 (42.9%) patients had normal PTH. 28 (100.0%) had low levels of PTH (< 15pg/ml) 23 (56.1%) had normal PTH developed biochemical hypocalcemia on POD 2–4. On 3 months follow up, 9(36%) patients who had low PTH and 1(2.9%) had persistent biochemical hypocalcemia. This was noted to be statically significant in predicting biochemical hypocalcemia (p = < 0.001). Change in PTH preoperatively and post operatively was also found to be just statically significant (p = 0.05) as shown in Graph 1.

On POD 1, 2–4, vitamin D was compared with calcium levels and was not found to be significant (P = 0.863, 0.932).

As described in Table 6, Specificity of post operative 4 h PTH and change in PTH was found to be 100% and 78.6% respectively, and PPV of 100% and 91.4% in predicting biochemical hypocalcemia.

Table 6

Post operative 4 h PTH change in PTH and preoperative Vitamin D as predictors of biochemical hypocalcemia

Parameter	4 h post operative PTH Value (95% CI)	Change in PTH Value (95% CI)	Vitamin D Value (95% CI)e (95% CI)
Cutoff (p value)	≤ 15.1 (0.017)	≤ -22.7 (0.05)	≤ 19.49 (0.074)
AUROC	0.707 (0.589–0.826)	0.666 (0.508–0.823)	0.656 (0.488–0.823)
Sensitivity	51.8% (38–65)	57.1% (43–70)	67.9% (54–80)
Specificity	100.0% (77–100)	78.6% (49–95)	71.4% (42–92)
Positive Predictive Value	100.0% (88–100)	91.4% (77–98)	90.5% (77–97)
Negative Predictive Value	34.1% (20–51)	31.4% (17–49)	35.7% (19–56)
Diagnostic Accuracy	61.4% (49–73)	61.4% (49–73)	68.6% (56–79)
Positive Likelihood Ratio	Inf (NaN-Inf)	2.67 (0.95–7.46)	2.38 (1.02–5.54)
Negative Likelihood Ratio	0.48 (0.37–0.63)	0.55 (0.36–0.82)	0.45 (0.27–0.75)
Diagnostic Odds Ratio	Inf (NaN-Inf)	4.89 (1.23–19.47)	5.28 (1.46–19.14)

Table 7

Post operative 4 h PTH change in PTH and preoperative Vitamin D as predictors of symptomatic hypocalcemia as shown in Table 7 and Graph 2.

Parameter	Post operative 4 h PTH Value (95% CI)	Change in PTH (95% CI)	Vitamin D Value (95% CI)
Cutoff (p value)	≤ 9.1 (< 0.001)	≤ -13.3 (0.001)	≥ 25.06 (0.771)
AUROC	0.847 (0.742–0.952)	0.734 (0.612–0.855)	0.521 (0.371–0.672)
Sensitivity	76.9% (56–91)	92.3% (75–99)	34.6% (17–56)
Specificity	88.6% (75–96)	47.7% (32–63)	84.1% (70–93)
Positive Predictive Value	80.0% (59–93)	51.1% (36–66)	56.2% (30–80)
Negative Predictive Value	86.7% (73–95)	91.3% (72–99)	68.5% (54–80)
Diagnostic Accuracy	84.3% (74–92)	64.3% (52–75)	65.7% (53–77)
Positive Likelihood Ratio	6.77 (2.89–15.86)	1.77 (1.3–2.39)	2.18 (0.92–5.14)
Negative Likelihood Ratio	0.26 (0.13–0.53)	0.16 (0.04–0.63)	0.78 (0.57–1.06)
Diagnostic Odds Ratio	26 (7.06–95.74)	10.96 (2.3-52.09)	2.8 (0.89–8.77)

Vitamin D has high PPV of 90.5% and diagnostic accuracy of biochemical hypocalcemia of 68.6%.

Post operative 4 h PTH and Specificity of 88% and NPV of 86% vitamin D has 84% specificity in predicting symptomatic hypocalcemia. Change in post operative PTH has NPV of 91% in predicting symptomatic hypocalcemia.

47 patients had benign final histopathology and 23 patients and malignant, this did not provide any statical significance in predicting biochemical or symptomatic hypocalcemia (p = 0.775, 1 respectively). 19 (27%) patients required post operative IV calcium correction, 52(74%) patients required oral calcium and 17 (24%) patients required additional vitamin D correction. 52 (76.5%) patients were given oral vitamin D and calcium supplementation on discharge.

Discussion

Total and near total thyroidectomy are routinely performed surgeries. Hypocalcemia is the complication which occurs 24–48 h after the surgery. This prolongs the hospital stay of the patient. Different investigators have used numerous parameters to predict the possibility of hypocalcemia post operatively.

In a study conducted by Noureldine et al. [6] 304 total thyroidectomies were performed, mild and significant hypocalcemia occurred in 22.4% and 29.9% patients respectively, 24% developed hypocalcemia-related symptoms. Mean age of patients who developed biochemical hypocalcemia was between 50.7 and 45.9 yrs (P = 0.02) with female preponderance (P = 0.003) which was statistically significant. 23.35% of the patients had preoperative diagnosis of Papillary neoplasm and 14.8% patients had goiter.

Guk Haeng Lee et al. [7] analysed 134 patients who underwent Total thyroidectomy for thyroid malignancies and developed laboratory and symptomatic hypocalcemia in 39% and 19% participants, on the day after surgery respectively. The mean age of patients who developed laboratory hypocalcemia was 52 ± 14 yrs with 46 female patients and mean age of 48 ± 10 yrs and 23 female patients developing symptomatic hypocalcemia.

In our study the youngest patient was 22 yrs and oldest patient was 77 yrs with a mean age of 46.03 ± 13.41 yrs. 30.8% patients who developed symptomatic hypocalcemia and 33.9% patients who developed biochemical hypocalcemia where between the age of 31–40 yrs respectively.

12.5% males and 87.5% females developed biochemical hypocalcemia respectively and 11.5% and 88.5% females presented with symptomatic hypocalcemia.

Postoperative and intraoperative serum-PTH has been analysed in various studies to predict hypocalcemia in post-total thyroidectomy [8‐10]. Noordzij et al. analysed 9 observational studies and found that 6 h post-operative PTH value in total thyroidectomies had sensitivity of 96.4% and specificity of 91.4% n detecting hypocalcemia postoperatively. Lombardi et al. measured PTH at 2, 4, 6, 24, and 48 h postoperatively and found that the best predictive value of hypocalcemia was given by PTH at 4 and 6 h. Payne et al. measured PTH 6, 12, 20 h postoperatively and concluded that 12 h PTH measurement was the most sensitive.

As there are no definitive guidelines for measuring postoperative PTH, we used 4 h post operative PTH as the predictor in our study. The cut-off of PTH is different in different studies [8‐13]. In the review conducted by Noordzij et al. [10], mean PTH was found to be 13.52 pg/mL in patients who developed post operative hypocalcemia. Payne et al. [8] found that Serum PTH levels less than 10 pg/ml was best predictor of post operative hypocalcemia. Asari et al. [14] and Roh and Park [15] found that the best predictor of hyocalcemia is PTH less than or equal to 15 pg/mL. Ramalingam et al. [16] showed that the postoperative PTH measured at 8 h post operatively, measuring 10 pg/mL had sensitivity of 68% and specificity of 73%.

Indian patients were found to have vitamin D deficiency in various studies [14‐16]. Preoperative vitamin-D is considered a predictor of hypocalcemia as it directly influences calcium metabolism [17, 18]. Lips et al. [19] has shown that low levels of vitamin D levels increased the chance of hypocalcemia by 28 times in patients who undergo total thyroidectomy. Ramalingam et al. [16] showed that vitamin D levels equal to or less than 20 ng/mL had sensitivity of 68% and specificity of 80% in predcting post operative hypocalcemia.

Abdollahi et al. [20] conducted a study where 35.1% patients had Vitamin D deficiency. 70% had postoperative Hypocalcemia on the first day and 86% on post operative day 2, but it was found not to be statically significant (P = 0.166).

In a study by Cherian et al. [21] Vitamin D deficiency was present in 53.3% participants, hypocalcemia was observed in 44.7% participants, of which there was similar distribution of hypocalcemia in patients with normal vitamin D and deficient groups(48.6% and 41.3%, respectively) P = 0.23, hence concluded that Vitamin D was not associated with hypocalcemia in post thyroidectomy patients.

In our study we analysed whether preoperative Vitamin D and 4 hour post operative PTH can reliably predict hypocalcemia in post operative period. 43 patients (61.4%) in our study had vitamin D deficiency (< 20ng/ml) which was significant. Vitamin-D deficiency however did not show any association with post operative hypocalcemia (P = 0.074). Vitamin D has 90.5% PPV and 71.4% specificity with a diagnostic accuracy of 68.6%.

The role of vitamin D in relation to thyroid and parathyroid is still being studied. Reports have shown that Vitamin D levels vary with stage of thyroid malignancy and autoimmune thyroiditis [22, 23]. Hence the possibility that vitamin D may be a marker for disease severity and not a predictor of hypocalcaemia.

In a study conducted by Lang et al. [24] out of the 17 patients who developed biochemical hypocalcemia in the post operative period, 9 patients had benign pathology(p = 0.028), 5 patients had grave’s disease and 3 patients had malignant final histopathology. Noureldine et al. [6] in his study with 304 patients 159 patients developed hypocalcemia of which 104 patients had malignant pathology which was found to be statistically significant. In our study, 34 patients who developed biochemical hypocalcemia had benign disease and 17 patients had malignant disease in the final histopathology which was not found to be statically significant.

Conclusion

Parathyroid hormone which is measured at 4 hour post operatively (< 15 pg/mL) and change in PTH after total and near total thyroidectomy accurately predicts post-operative hypocalcemia. The early detection of patients who are at risk of developing post-operative hypocalcemia facilitates prompt supplementation of calcium and Vitamin D and reduces morbidity, life threatening complications and permits early discharge.

Declarations

Disclosure

The authors declare no conflict of interest.

Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Jetzt informieren

e.Med Interdisziplinär

Kombi-Abonnement

Jetzt e.Med zum Sonderpreis bestellen!

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt bestellen und 100 € sparen!

Jetzt testen ¹

e.Dent – Das Online-Abo der Zahnmedizin

Online-Abonnement

Mit e.Dent erhalten Sie Zugang zu allen zahnmedizinischen Fortbildungen und unseren zahnmedizinischen und ausgesuchten medizinischen Zeitschriften.

Jetzt testen ²

e.Med HNO

Kombi-Abonnement

Mit e.Med HNO erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes HNO, den Premium-Inhalten der HNO-Fachzeitschriften, inklusive einer gedruckten HNO-Zeitschrift Ihrer Wahl.

Jetzt testen ³

Proczko-Markuszewska M, Kobiela J, Stefaniak T, Łachiński AJ, Śledziński Z (2010) Postoperative PTH Measurement as a Predictor of Hypocalcaemia after Thyroidectomy. undefined. 110(1):40–44. doi:https://doi.org/10.1080/00015458.2010.11680563

Harrison’s Principles Of Internal Medicine 20th Edition PDF (2018): Free Download, Borrow, and Streaming: Internet Archive. Accessed November 17, 2022. https://archive.org/details/harrison-20th-edition

Libutti SK, Bartlett DL, Jaskowiak NT et al (1997) The role of thyroid resection during reoperation for persistent or recurrent hyperparathyroidism. Surgery 122(6):1183–1188. https://doi.org/10.1016/S0039-6060(97)90225-7CrossRefPubMed

Farr HW, Fahey TJ, Nash AG, Farr CM (1973) Primary hyperparathyroidism and cancer. Am J Surg 126(4):539–543. https://doi.org/10.1016/S0002-9610(73)80046-7CrossRefPubMed

Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281. https://doi.org/10.1056/NEJMRA070553CrossRefPubMed

Noureldine SI, Genther DJ, Lopez M, Agrawal N, Tufano RP (2014) Early predictors of hypocalcemia after total thyroidectomy: an analysis of 304 patients using a short-stay monitoring protocol. JAMA Otolaryngol Head Neck Surg 140(11):1006–1013. https://doi.org/10.1001/JAMAOTO.2014.2435CrossRefPubMedPubMedCentral

Lee GH, Ku YH, Kim H, il, Lee MC, Kim MJ (2015) Vitamin D level is not a predictor of hypocalcemia after total thyroidectomy. Langenbecks Arch Surg 400(5):617–622. https://doi.org/10.1007/S00423-015-1311-1/TABLES/4CrossRefPubMed

Payne RJ, Hier MP, Tamilia M, Young J, MacNamara E, Black MJ (2003) Postoperative parathyroid hormone level as a predictor of post-thyroidectomy hypocalcemia. J Otolaryngol 32(6):362–367. https://doi.org/10.2310/7070.2003.13985CrossRefPubMed

Lo CY, Luk JM, Tam SC (2002) Applicability of intraoperative parathyroid hormone assay during thyroidectomy. Ann Surg 236(5):564–569. https://doi.org/10.1097/00000658-200211000-00005CrossRefPubMedPubMedCentral

10.

Noordzij JP, Lee SL, Bernet VJ et al (2007) Early prediction of hypocalcemia after thyroidectomy using parathyroid hormone: an analysis of pooled individual patient data from nine observational studies. J Am Coll Surg 205(6):748–754. https://doi.org/10.1016/J.JAMCOLLSURG.2007.06.298CrossRefPubMed

11.

Yamashita H, Noguchi S, Murakami T et al (2001) Predictive risk factors for postoperative tetany in female patients with graves’ disease. J Am Coll Surg 192(4):465–468. https://doi.org/10.1016/S1072-7515(01)00803-1CrossRefPubMed

12.

Erbil Y, Barbaros U, Temel B et al (2009) The impact of age, vitamin D(3) level, and incidental parathyroidectomy on postoperative hypocalcemia after total or near total thyroidectomy. Am J Surg 197(4):439–446. https://doi.org/10.1016/J.AMJSURG.2008.01.032CrossRefPubMed

13.

Lombardi CP, Raffaelli M, Princi P et al (2004) Early prediction of postthyroidectomy hypocalcemia by one single iPTH measurement. Surgery 136(6):1236–1241. https://doi.org/10.1016/j.surg.2004.06.053CrossRefPubMed

14.

Asari R, Passler C, Kaczirek K, Scheuba C, Niederle B (2008) Hypoparathyroidism after total thyroidectomy: a prospective study. Arch Surg 143(2):132–137. https://doi.org/10.1001/ARCHSURG.2007.55CrossRefPubMed

15.

Roh JL, Park C (2006) il. Intraoperative parathyroid hormone assay for management of patients undergoing total thyroidectomy. Head Neck. 28(11):990–997. doi:https://doi.org/10.1002/HED.20444

16.

Pradeep P, Ramalingam K, Jayashree B (2013) Post total thyroidectomy hypocalcemia: a novel multi-factorial scoring system to enable its prediction to facilitate an early discharge. J Postgrad Med 59(1):4–8. https://doi.org/10.4103/0022-3859.109479CrossRefPubMed

17.

Sai AJ, Walters RW, Fang X, Gallagher JC (2011) Relationship between vitamin D, parathyroid hormone, and bone health. J Clin Endocrinol Metab 96(3). https://doi.org/10.1210/JC.2010-1886

18.

Lips P, Wiersinga A, van Ginkel FC et al (1988) The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 67(4):644–650. https://doi.org/10.1210/JCEM-67-4-644CrossRefPubMed

19.

Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22(4):477–501. https://doi.org/10.1210/EDRV.22.4.0437CrossRefPubMed

20.

Abdollahi A, Nakhjavani M, Alibakhshi A, Mohammadifard M (2017) Is there any relationship between serum level of vitamin D and postoperative hypocalcemia after total thyroidectomy? Biomedical & Pharmacology Journal 10(1):207–211. https://doi.org/10.13005/bpj/1099CrossRef

21.

Cherian AJ, Ponraj S, Gowri SM et al (2016) The role of vitamin D in post-thyroidectomy hypocalcemia: still an enigma. Surgery 159(2):532–538. https://doi.org/10.1016/J.SURG.2015.08.014CrossRefPubMed

22.

Choi YM, Kim WG, Kim TY et al (2014) Low levels of serum vitamin D3 are associated with autoimmune thyroid disease in pre-menopausal women. Thyroid 24(4):655–661. https://doi.org/10.1089/THY.2013.0460CrossRefPubMedPubMedCentral

23.

Kim JR, Kim BH, Kim SM et al (2014) Low serum 25 hydroxyvitamin D is associated with poor clinicopathologic characteristics in female patients with papillary thyroid cancer. Thyroid 24(11):1618–1624. https://doi.org/10.1089/THY.2014.0090CrossRefPubMed

24.

Lang BHH, Yih PCL, Ng KK (2012) A prospective evaluation of quick intraoperative parathyroid hormone assay at the time of skin closure in predicting clinically relevant hypocalcemia after thyroidectomy. World J Surg 36(6):1300–1306. https://doi.org/10.1007/S00268-012-1561-9/TABLES/5CrossRefPubMedPubMedCentral

Titel: Serum Parathyroid Hormone and Vitamin D Levels as Predictors of Hypocalcemia after Total/ Near Total Thyroidectomy
verfasst von: Priya Dugani
Poorvi V Sharma
Sunil M Krishna
Krishna Kalyan Reddy
Publikationsdatum: 03.03.2023
Verlag: Springer India
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe 3/2023
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI: https://doi.org/10.1007/s12070-023-03599-3

Neu im Fachgebiet HNO

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Serum Parathyroid Hormone and Vitamin D Levels as Predictors of Hypocalcemia after Total/ Near Total Thyroidectomy

Abstract

Publisher’s Note

Introduction

Methods

Results

Discussion

Conclusion